R.F. Shenker
Papers
1
Total Citations
22
H-Index
1
About
R.F. Shenker is a leading clinical researcher in head and neck oncology, with a focused expertise in the treatment of human papillomavirus-associated oropharyngeal squamous cell carcinoma. Their major contribution lies in directly comparing the outcomes of primary transoral robotic surgery (TORS) versus radiotherapy (RT) for early-stage HPV-positive disease. In their landmark 2023 study, Shenker rigorously investigated progression-free survival, overall survival, and—critically—1-year swallowing function, providing vital evidence to guide treatment de-escalation strategies. This work, which has already garnered 22 citations, helps clinicians and patients weigh oncologic control against functional quality of life. By addressing the pressing question of how to minimize long-term toxicity without compromising survival, Shenker’s research has a tangible impact on clinical decision-making. Their work is essential reading for surgeons, radiation oncologists, and researchers striving to optimize personalized, function-preserving care for this growing patient population.
Research Focus
Key Achievements
Top Papers
- 1